<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Pediatr Parent</journal-id><journal-id journal-id-type="publisher-id">pediatrics</journal-id><journal-id journal-id-type="index">30</journal-id><journal-title>JMIR Pediatrics and Parenting</journal-title><abbrev-journal-title>JMIR Pediatr Parent</abbrev-journal-title><issn pub-type="epub">2561-6722</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v8i1e70049</article-id><article-id pub-id-type="doi">10.2196/70049</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Increasing Vaccination Awareness for Italian Primary Care Pediatricians: Game Design and Usability Study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Marchetti</surname><given-names>Federico</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barretta</surname><given-names>Martino</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Di Mauro</surname><given-names>Antonio</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bona</surname><given-names>Marco</given-names></name><degrees>BSc</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Amerighi</surname><given-names>Chiara</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>D'Avino</surname><given-names>Antonio</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff5">5</xref></contrib></contrib-group><aff id="aff1"><institution>GSK</institution><addr-line>Viale dell'Agricoltura 7</addr-line><addr-line>Verona</addr-line><country>Italy</country></aff><aff id="aff2"><institution>Federazione Italiana Medici Pediatri</institution><addr-line>Crotone</addr-line><country>Italy</country></aff><aff id="aff3"><institution>Federazione Italiana Medici Pediatri</institution><addr-line>Bari</addr-line><country>Italy</country></aff><aff id="aff4"><institution>Choralia Comunicazione Interna e Formazione Srl</institution><addr-line>Milan</addr-line><country>Italy</country></aff><aff id="aff5"><institution>Federazione Italiana Medici Pediatri</institution><addr-line>Naples</addr-line><country>Italy</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Badawy</surname><given-names>Sherif</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Singgih</surname><given-names>Ivan Kristianto</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Bloomfield</surname><given-names>Lauren Edna</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Federico Marchetti, MSc, GSK,, Viale dell'Agricoltura 7, Verona, 37135, Italy, 39 0457741111; <email>federico.e.marchetti@gsk.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>3</day><month>11</month><year>2025</year></pub-date><volume>8</volume><elocation-id>e70049</elocation-id><history><date date-type="received"><day>13</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>21</day><month>07</month><year>2025</year></date><date date-type="accepted"><day>17</day><month>08</month><year>2025</year></date></history><copyright-statement>&#x00A9; Federico Marchetti, Martino Barretta, Antonio Di Mauro, Marco Bona, Chiara Amerighi, Antonio D'Avino. Originally published in JMIR Pediatrics and Parenting (<ext-link ext-link-type="uri" xlink:href="https://pediatrics.jmir.org">https://pediatrics.jmir.org</ext-link>), 3.11.2025. </copyright-statement><copyright-year>2025</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Pediatrics and Parenting, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://pediatrics.jmir.org">https://pediatrics.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://pediatrics.jmir.org/2025/1/e70049"/><abstract><sec><title>Background</title><p>Invasive meningococcal disease has a high fatality rate and can lead to severe long-term health issues. In Europe, serogroup B meningococcal disease (MenB) accounts for over half of invasive meningococcal disease cases. In Italy, MenB vaccination is recommended for all newborns, but the uptake is below the Ministry of Health Vaccination Plan target (uptake: 80.91%; target: 90%).</p></sec><sec><title>Objective</title><p>A vaccine-based digital educational tool, Meningioca, was designed to increase primary care pediatricians&#x2019; (PCPs&#x2019;) knowledge on the value and proper timing of MenB vaccination and to support communication of this value to parents.</p></sec><sec sec-type="methods"><title>Methods</title><p>Meningioca was developed using Articulate, an authoring software, and released via the TalentLMS online platform. Players engaged in a sequence of activities and mini-games, taking on the role of a PCP and progressing through 7 modules. Each module corresponds to a different age group and follows a fixed sequence of topics, simulating typical discussions that might occur during health checks for each specific age group. At the launch, members of the Italian Federation of PCPs were invited to play the game via an email link and rated the game based on aspects such as overall enjoyment, the difficulty of modules, and usefulness of the game as a teaching tool.</p></sec><sec sec-type="results"><title>Results</title><p>Between March 2023 and May 2024, 471 PCPs accessed Meningioca, completing 1206 modules and 482 hours of learning. Meningioca received a mean rating of 4.4/5 (5 being the highest score), with many participants noting that they would recommend Meningioca to a colleague. &#x201C;Communicating with the parent&#x201D; and &#x201C;health checks&#x201D; were voted as participants&#x2019; favorite module topics; &#x201C;general culture&#x201D; and &#x201C;child growth and development&#x201D; were voted as the most difficult. At the end of Module 3, 75% (n/N=50/67) of players agreed that Meningioca was a teaching tool to refresh and strengthen knowledge to a high or very high extent.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>User feedback from Meningioca&#x2019;s first year suggests that the game is enjoyable and a potentially valuable learning tool for increasing PCPs&#x2019; knowledge on vaccination.</p></sec></abstract><kwd-group><kwd>primary care pediatricians</kwd><kwd>health education</kwd><kwd>immunization</kwd><kwd>meningococcal serogroup B</kwd><kwd>vaccination</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Invasive meningococcal disease (IMD) is caused by <italic>Neisseria meningitidis</italic>. Despite its low incidence in Europe (0.1 cases per 100,000 individuals), IMD is a public health concern due to its high fatality rate (13% in infants aged &#x003C;1 y) and severe long-term health implications [<xref ref-type="bibr" rid="ref1">1</xref>].</p><p>In Europe, serogroup B meningococcal disease (MenB) is the leading cause of IMD, responsible for more than 50% of serogroup-documented cases. Recent national surveillance data from Italy also highlight MenB as the most common cause of IMD in the country [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>]. MenB vaccination in Italy is offered as a 2-dose primary course (starting from &#x2265;2 mo of age and subsequent dose 2 mo later) and 1 booster dose (at 13&#x2010;14 mo of age; a 2+1 schedule) [<xref ref-type="bibr" rid="ref3">3</xref>]. However, MenB vaccination is recommended, not mandatory, in Italy [<xref ref-type="bibr" rid="ref4">4</xref>] and nonmandatory vaccinations may be viewed as less important than mandatory vaccinations by citizens and health workers [<xref ref-type="bibr" rid="ref5">5</xref>].</p><p>Due to the high incidence of invasive MenB cases in individuals aged under 1 year, studies analyzing both Italian and UK cohorts have highlighted the importance of starting a vaccination schedule as early as possible [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref8">8</xref>]. In two retrospective, observational studies, MenB vaccination in children aged &#x003C;6 years was shown to be highly effective at preventing the disease [<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>]. However, despite the proven efficacy of MenB vaccination, mean MenB vaccination coverage in Italy for the 2020 birth cohort was reported to be 80.91% and therefore, lower than the Italian Ministry of Health&#x2019;s target of 90% [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref9">9</xref>].</p><p>In Italy, primary care pediatricians (PCPs) are expected to perform scheduled health checks, recommend vaccinations, and verify the vaccination status of children. In a survey conducted by the Italian Federation of Pediatricians (FIMP) in 2019, out of over 1000 responses, approximately 80% of PCPs said they stress the importance of vaccinations during health checks, but nearly half said they do not proactively arrange such health checks [<xref ref-type="bibr" rid="ref10">10</xref>]. Although it is widely understood that vaccination is important for disease prevention, parental vaccine hesitancy is a known barrier to adherence to childhood vaccinations, with reasons for vaccine hesitancy including concerns about the busy pediatric vaccination schedule, vaccine effectiveness, and vaccine safety [<xref ref-type="bibr" rid="ref11">11</xref>]. Between below-target vaccination coverage and vaccine hesitancy among parents, there is a need for effective communication about the value of recommended vaccinations in order to increase vaccine uptake [<xref ref-type="bibr" rid="ref12">12</xref>].</p><p>Serious games and gamification allow participants to learn in an experiential, learning-by-doing way through making content more engaging, facilitating improvement of knowledge, and offering a measure of progress to create healthy competition, encouraging participants to learn more [<xref ref-type="bibr" rid="ref13">13</xref>]. The use of serious games to improve knowledge and skills of health care professionals has been shown to be as effective as traditional learning methods, such as learning from written text or lectures [<xref ref-type="bibr" rid="ref13">13</xref>]. In the context of vaccines, digital gamification has been suggested to hold potential to increase vaccination knowledge and thereby coverage. The use of gamification to enhance vaccine uptake is a rapidly expanding field [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref>]; a scoping review published in 2020 found only 7 peer-reviewed articles evaluating gamified digital tools to increase vaccine knowledge; a similar study published in 2024 identified 28 such articles, a four-fold increase [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref>].</p><p>The aim of this project was to develop a digital gamified educational training tool, Meningioca, to inform PCPs of the value and proper timing of vaccination with a focus on MenB and to improve communication of this value to parents and caregivers.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Game Concept</title><p>Meningioca was designed in partnership with the FIMP, which comprises of over 5300 Italian PCPs (the target audience for Meningioca). Meningioca was designed by a multiprofessional core team comprised of family pediatricians (end-users), professionals with experience and skills in online or remote learning, and professionals with documented scientific expertise in vaccines and vaccinations, through a design-thinking approach [<xref ref-type="bibr" rid="ref16">16</xref>].</p><p>For Meningioca, the design-thinking approach began with understanding the needs of the end-users (ie, PCPs). To ensure all required information was included, a map of topics discussed during health checks was generated (<xref ref-type="other" rid="box1">Textbox 1</xref>). Unique ideas to communicate this information to end-users in an innovative and engaging way were discussed, and gamification was identified as a potential solution. The map of health check topics was then adapted to suit a serious game, forming the basis of Meningioca&#x2019;s content.</p><boxed-text id="box1"><title> Contents discussed during each health check-up formed the basis of Meningioca&#x2019;s modules. Each health check is intended to occur at a specific age. The contents of each health check are in line with this age and aim to monitor the physiological development of children and inform parents about preventable diseases.</title><p><bold>Health check 1</bold></p><list list-type="bullet"><list-item><p>Tasks to be done</p></list-item><list-item><p>Vaccination status</p></list-item><list-item><p>Meningitis B &#x2013; characteristics and diagnosis</p></list-item><list-item><p>Early autism diagnosis</p></list-item><list-item><p>Communicate with the caregiver</p></list-item><list-item><p>Nutrition and breastfeeding</p></list-item></list><p><bold>Health check 2</bold></p><list list-type="bullet"><list-item><p>Tasks to be done</p></list-item><list-item><p>General culture</p></list-item><list-item><p>Vaccination status</p></list-item><list-item><p>Hunger signals</p></list-item><list-item><p>Meningitis B &#x2013; lethality and disability</p></list-item><list-item><p>Communicate with the caregiver</p></list-item></list><p><bold>Health check 3</bold></p><list list-type="bullet"><list-item><p>Tasks to be done</p></list-item><list-item><p>General culture</p></list-item><list-item><p>Meningitis B &#x2013; symptoms</p></list-item><list-item><p>Vaccination status</p></list-item><list-item><p>External body obstruction</p></list-item><list-item><p>Communicate with the caregiver</p></list-item><list-item><p>Weaning</p></list-item></list><p><bold>Health check 4</bold></p><list list-type="bullet"><list-item><p>Tasks to be done</p></list-item><list-item><p>Meningitis B &#x2013; doses and serogroups</p></list-item><list-item><p>Vaccination status</p></list-item><list-item><p>Neurodevelopmental assessment of the child</p></list-item><list-item><p>Communicate with the caregiver</p></list-item><list-item><p>Babbling and language development</p></list-item></list><p><bold>Health check 5</bold></p><list list-type="bullet"><list-item><p>Tasks to be done</p></list-item><list-item><p>Child's oral hygiene</p></list-item><list-item><p>Vaccination status</p></list-item><list-item><p>Meningitis B &#x2013; spread and transmission</p></list-item><list-item><p>Risks of using digital devices</p></list-item><list-item><p>Live attenuated virus vaccination</p></list-item><list-item><p>Communicate with the caregiver</p></list-item></list><p><bold>Health check 6</bold></p><list list-type="bullet"><list-item><p>Tasks to be done</p></list-item><list-item><p>Scoliosis and posture</p></list-item><list-item><p>Vaccination status</p></list-item><list-item><p>Meningitis B &#x2013; permanent disabilities</p></list-item><list-item><p>Communicate with the caregiver</p></list-item><list-item><p>Abilities at every age group</p></list-item></list><p><bold>Health check 7</bold></p><list list-type="bullet"><list-item><p>Tasks to be done</p></list-item><list-item><p>Sense of risk</p></list-item><list-item><p>Vaccination status</p></list-item><list-item><p>Meningitis B &#x2013; contagion in adolescence</p></list-item><list-item><p>General knowledge (adolescent language)</p></list-item><list-item><p>Communicate with the caregiver</p></list-item><list-item><p>Sexual experience</p></list-item></list></boxed-text></sec><sec id="s2-2"><title>Game Design</title><p>Meningioca was developed using Storyline 360 (a suite of Articulate 360), an authoring software, SCORM 1.2 (standard format), and TalentLMS, a learning management platform [<xref ref-type="bibr" rid="ref17">17</xref>-<xref ref-type="bibr" rid="ref19">19</xref>]. Participants play as an avatar of a goose, inspired by the Game of the Goose (a well-known board game that originated in Italy in the 15th century) and take on the role of a PCP. Using a narrative approach, players participate in a series of activities and mini-games, using and improving vaccination knowledge. Examples of the mini-games include a drag-and-drop activity, where users separate actions they would and would not carry out during health checks, as well as a quick-fire selection game, where users scroll through a video and click on correct answers to questions posed. Participants received points and feedback after each mini-game, with points gained the first time a module is played and players ranked against all other participants. Once each module had been unlocked, it was freely accessible for review or to refresh training. All data included in Meningioca are supported by a reference, either from scientific or gray literature, to ensure all information is confirmed with a reliable source.</p></sec><sec id="s2-3"><title>Game Refinement and Structure</title><p>A prototype of one module was played by 10 PCPs. Feedback from these testers suggested that the game was enjoyable, and further modules were produced. At launch (March 2023), Meningioca was comprised of 6 modules, with each module focusing on a different age group (0&#x2010;2, 2&#x2010;3, 4&#x2010;6, 12&#x2010;15, 24, and 60&#x2010;72 mo of age), selected to be in line with the Italian national immunization calendar. In April 2024, a 7th module focusing on adolescents (11&#x2010;14 y of age) was added (<xref ref-type="fig" rid="figure1">Figure 1</xref>).</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Meningioca modules.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v8i1e70049_fig01.png"/></fig><p>All modules within Meningioca are based on a fixed sequence of topics, mirroring discussions that could be expected during health checks for each age group. In brief, the following main themes are covered: health checks in general, child growth or development, vaccination calendar and immunization status check, deepening MenB understanding, communicating with the parent, and Italian general culture. The modules use elements of surprise via quizzes and involve role-playing scenarios where users interact with avatars of colleagues (<xref ref-type="fig" rid="figure2">Figure 2</xref>) and caregivers (<xref ref-type="fig" rid="figure3">Figure 3</xref>).</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Example scenes from Meningioca depicting interactions with colleagues. Text from the game has been translated from Italian into English.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v8i1e70049_fig02.png"/></fig><fig position="float" id="figure3"><label>Figure 3.</label><caption><p>Example scenes from Meningioca depicting interactions with caregivers. Text from the game has been translated from Italian into English.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v8i1e70049_fig03.png"/></fig></sec><sec id="s2-4"><title>Game Launch</title><p>At the launch of Meningioca in March 2023, members of the FIMP were invited to play the game via an email link. Members who subscribed to the game were notified of the launch of the module in April 2024. The effectiveness of Meningioca to educate PCPs on the value and proper timing of vaccination with a focus on MenB was measured via feedback questionnaires at the end of each module (<xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>).</p></sec><sec id="s2-5"><title>Ethical Considerations</title><p>Meningioca was an educational project, not involving a human subject scheme nor collecting human data. Therefore, this project did not require ethics review as per the Linea Guida per la classificazione e conduzione degli studi osservazionali sui farmaci (GU Serie Generale n.76 del 31-03-2008) [<xref ref-type="bibr" rid="ref20">20</xref>].</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>Between March 2023 and May 2024, 471 PCPs accessed Meningioca and 1206 modules were completed, comprising 482 hours of learning. After Module 6, players were asked to rate their enjoyment of Meningioca on a scale from 1 to 5, with 5 being the highest score. Meningioca received a mean rating of 4.4/5. Participants were also asked to rate individual modules at the end of Modules 1&#x2010;6, and a breakdown of ratings is reported in <xref ref-type="fig" rid="figure4">Figure 4</xref>.</p><fig position="float" id="figure4"><label>Figure 4.</label><caption><p>Proportion of PCPs rating each module on a scale of 1&#x2010;5 from March 2023 to September 2023. At the end of each module, PCPs were asked to rate how much they liked the module on a scale of 1&#x2010;5, with 5 as the highest score. PCP: primary care pediatrician.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v8i1e70049_fig04.png"/></fig><p>After Modules 3&#x2010;7, participants were asked to select their favorite topic and the topic that they found most difficult. There was a relatively even split regarding participants&#x2019; favorite topics; &#x201C;communicating with the parent&#x201D; and &#x201C;health checks&#x201D; received the most votes and &#x201C;general culture&#x201D; received the fewest (<xref ref-type="fig" rid="figure5">Figure 5A</xref>). &#x201C;General culture&#x201D; and &#x201C;child growth and development&#x201D; were voted as the most difficult module topics (<xref ref-type="fig" rid="figure5">Figure 5B</xref>).</p><fig position="float" id="figure5"><label>Figure 5.</label><caption><p>Proportion of PCPs that rated different topics within Meningioca as (<bold>A</bold>) the topic they liked the most and (<bold>B</bold>) the topic they found the most difficult. At the end of Modules 3&#x2010;7, PCPs were asked to choose their favorite topic within the module and the topic they found most difficult. MenB: serogroup B meningococcal disease; PCP: primary care pediatrician.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v8i1e70049_fig05.png"/></fig><p>On completion of certain modules, participants were asked whether they would recommend Meningioca to a colleague. Overall, 93% (n/N=63/68) answered &#x201C;yes&#x201D; at the end of Module 3, 90% (n/N=53/59) at Module 4, 90% (n/N=53/59) at Module 5, with the remaining participants answering &#x201C;No.&#x201D; Additionally, at the end of Module 3, participants were asked to what extent Meningioca could be considered a teaching tool to refresh/strengthen knowledge, with a response scale from &#x201C;very little&#x201D; to &#x201C;very much&#x201D;; 43% (n/N=29/67) of participants answered &#x201C;a lot&#x201D; and 32% (n/N=21/67) of participants answered &#x201C;very much&#x201D;.</p></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>To the best of our knowledge, Meningioca is the first gamified educational training tool developed within the field of vaccination, specifically designed for PCPs in Italy. The primary aim of Meningioca is to increase PCPs&#x2019; knowledge on the importance of health checks within the context of childhood vaccination and, on a larger scale, boost the below-target MenB vaccination coverage in Italy and decrease general vaccine hesitancy among parents. Early results from the first 14 months of use indicate that Meningioca is not only an enjoyable game but also serves as an effective teaching tool to refresh and strengthen vaccination knowledge.</p></sec><sec id="s4-2"><title>Comparison to Prior Work</title><p>Meningioca adds to the rapidly expanding field of digital vaccination-based serious gamification tools. Over the past 10 years, digital learning methods aimed at enhancing vaccination knowledge and programs have transitioned from being limited in use to becoming well established, with this evolution evidenced by the increasing number of these games available [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref21">21</xref>]. Meningioca, like many vaccine-based digital gamification tools, was aimed at a specific population [<xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref23">23</xref>]. Understanding the needs of the end-user is key for an engaging learning tool, and by focusing on one target group, the effectiveness of digital gamification tools can be maximized. PCPs were closely involved in the development of Meningioca, both as part of the initial multiprofessional design team and as testers of the pilot module. Involving the end-user from an early stage of development is a valuable strategy for tailoring the needs of a game and may have contributed to players&#x2019; enjoyment of Meningioca [<xref ref-type="bibr" rid="ref15">15</xref>]. Furthermore, Meningioca reinforces the idea that digital gamification tools can be effective even in cohorts with a high level of base knowledge, as demonstrated in a previous study involving antibiotics and vaccination games, where senior students&#x2019; knowledge improved despite already possessing high baseline knowledge in these areas [<xref ref-type="bibr" rid="ref22">22</xref>]. At present, the majority of vaccine-based digital gamification tools focus on one type of disease, such as influenza or human papillomavirus [<xref ref-type="bibr" rid="ref15">15</xref>]. While Meningioca focuses on MenB vaccination, it also includes information on other childhood vaccinations, topics discussed during health checks, and general Italian culture. By including information on multiple childhood vaccinations, Meningioca ensures PCPs gain interconnected knowledge between different vaccinations, which may lead to a more comprehensive understanding and an increased ability to apply this knowledge more broadly. The web-based nature of Meningioca enhances its ease of use, as no downloadable content or additional devices are required to participate. While the impact of the type of platform used to deliver the tools, eg, web-based, mobile, or virtual reality has not currently been evaluated in terms of user preference, this web-based approach aligns with the majority of vaccine-related digital gamified tools [<xref ref-type="bibr" rid="ref15">15</xref>].</p><p>Feedback from Meningioca&#x2019;s first year indicated that the game is well-rated among players and enjoyable, as evidenced by Meningioca&#x2019;s mean rating of 4.4/5. The even split between players&#x2019; favorite topics within modules suggests that the game offers a balanced experience, with each aspect developed to a high quality throughout. Enjoyment has been shown to have a positive effect on learning and memory, suggesting that Meningioca may be more effective at increasing knowledge if players enjoy it [<xref ref-type="bibr" rid="ref24">24</xref>]. &#x201C;Communicating with parents,&#x201D; consistently one of the PCPs&#x2019; favorite topics, was voted as one of the least difficult, suggesting enjoyment and difficulty may be linked. As no single topic received an overwhelming majority of votes as the most difficult, it could be implied that players of a digital gamification tool need to experience a balanced level of challenge. This balance is crucial for effective learning, as players should feel challenged enough to engage in the game&#x2019;s content, but not too much that it becomes overwhelming. Overall, early results suggest Meningioca was well received and is an effective tool to increase vaccination knowledge.</p><p>In Italy, regular health checks from birth to the age of 14 years are recommended to monitor the physiological development of children and inform parents about preventable diseases, including raising awareness of these diseases and encouraging caregivers to ensure their children receive available vaccinations. Nonetheless, many PCPs do not proactively schedule these appointments, potentially leading to gaps in preventive care and lapses in vaccination schedule adherence, ultimately impacting the child&#x2019;s overall immunization profile [<xref ref-type="bibr" rid="ref10">10</xref>]. Enhancing PCPs&#x2019; knowledge on the importance of vaccination may not only encourage them to proactively arrange future health checks but also improve their ability to effectively communicate this information to parents, thereby reducing parental vaccine hesitancy, fostering increased vaccine adherence, and helping to prevent the spread of disease. While it is not possible to measure this directly, by encouraging both PCPs to carry out more health checks and parents to take their children to receive vaccinations, Meningioca could boost childhood vaccination uptake, potentially leading to Italy meeting its national MenB vaccination coverage target.</p></sec><sec id="s4-3"><title>Strengths and Limitations</title><p>The ability of Meningioca to act as an effective teaching tool was strengthened by the inclusion of PCPs in its development. A large number of Italian PCPs were invited to play the game, improving the game&#x2019;s generalizability and aiming to ensure that the players accurately represent PCPs overall. Despite these strengths, Meningioca was associated with limitations. First, feedback questionnaires were not consistent across modules, leading to data gaps when synthesizing responses. Consistent questions across modules may help in building a more comprehensive view of the perceptions of end-users. Second, the impact of Meningioca, in terms of its ability to reduce caregiver vaccine hesitancy and increase vaccine uptake, cannot be directly measured. Surrogate measures such as enjoyment and Meningioca&#x2019;s use as a learning tool could instead be used as proxies.</p></sec><sec id="s4-4"><title>Future Directions</title><p>Further feedback from users will be essential for the improvement of Meningioca as a tool to increase vaccine knowledge among Italian PCPs. Meningioca will continue to be a live game for PCPs to access, in order to increase their knowledge on health check activities as well as their knowledge on vaccinations. Specific questions that test PCPs&#x2019; vaccine knowledge before and after using the training tool may help to quantify the effectiveness of Meningioca as a resource for increasing PCPs&#x2019; knowledge. Further validation will need to be carried out to assess whether Meningioca could be effective in reducing caregiver vaccine hesitancy and increasing MenB vaccine uptake.</p></sec><sec id="s4-5"><title>Conclusions</title><p>Digital gamification tools are an innovative and promising option for developing vaccination-related learning tools. Meningioca is an enjoyable and potentially effective educational resource for increasing PCP knowledge on the value and proper timing of vaccination, particularly MenB vaccination.</p></sec></sec></body><back><ack><p>The authors thank Costello Medical for editorial assistance and publication coordination, on behalf of GSK, and acknowledge Hannah Russell, Costello Medical, UK, for medical writing and editorial assistance based on authors&#x2019; input and direction.</p><p>Financial costs associated with this project were supported by GSK. Support for third-party writing assistance for this article, provided by Hannah Russell, Costello Medical, UK, was funded by GSK in accordance with Good Publication Practice (GPP 2022) guidelines [<xref ref-type="bibr" rid="ref25">25</xref>].</p></ack><notes><sec><title>Data Availability</title><p>Data available are those on which the manuscript is based. Files are stored in the GSK repository; no other data will be disclosed unless FIMP consider it of interest.</p></sec></notes><fn-group><fn fn-type="con"><p>Substantial contributions to study conception and design: FM, MBarretta, ADM, MBona, CA, ADA; substantial contributions to analysis and interpretation of the data: FM, MBarretta, ADM, MBona, CA, ADA; drafting the article or revising it critically for important intellectual content: FM, MBarretta, ADM, MBona, CA, ADA; final approval of the version of the article to be published: FM, MBarretta, ADM, MBona, CA, ADA.</p></fn><fn fn-type="conflict"><p>FM: Employed by GSK and holds financial equities in GSK. ADM: Honoraria for AstraZeneca speaker/presentations and Angelini manuscript writing; unpaid GSK video interview contract, unpaid roles for Italian Society of Pediatrics (SIP) and Italian Federation of Primary Care Pediatricians (FIMP). MBarretta, ADA, MBona, CA: Nothing to disclose.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">FIMP</term><def><p>Italian Federation of Pediatricians</p></def></def-item><def-item><term id="abb2">IMD</term><def><p>invasive meningococcal disease</p></def></def-item><def-item><term id="abb3">MenB</term><def><p>serogroup B meningococcal disease</p></def></def-item><def-item><term id="abb4">PCP</term><def><p>primary care pediatrician</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="report"><article-title>Invasive Meningococcal Disease: Annual Epidemiological Report for 2021-2023</article-title><access-date>2024-02-20</access-date><publisher-name>European Centre for Disease Prevention and Control</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/sites/default/files/documents/MEN%20AER%202021.pdf">https://www.ecdc.europa.eu/sites/default/files/documents/MEN%20AER%202021.pdf</ext-link></comment></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="web"><article-title>Sorveglianza nazionale delle malattie batteriche invasive (National Surveillance of Invasive Bacterial Diseases Data 2021-2023)</article-title><source>Istituto Superiore di Sanit&#x00E0;</source><year>2024</year><access-date>2025-09-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.iss.it/documents/20126/6703853/RIS+2-2024.pdf/67f460ad-111b-9fd9-24bd-4e23160ad864?t=1727273034488">https://www.iss.it/documents/20126/6703853/RIS+2-2024.pdf/67f460ad-111b-9fd9-24bd-4e23160ad864?t=1727273034488</ext-link></comment></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="web"><article-title>Piano nazionale prevenzione vaccinale PNPV 2023-2025</article-title><source>Presidenza del Consiglio dei Ministri</source><year>2023</year><access-date>2025-09-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.quotidianosanita.it/allegati/allegato1679488094.pdf">https://www.quotidianosanita.it/allegati/allegato1679488094.pdf</ext-link></comment></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="web"><article-title>Italy: recommended vaccinations</article-title><source>European Centre for Disease Prevention and Control</source><access-date>2025-09-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://tinyurl.com/ynmpnffx">https://tinyurl.com/ynmpnffx</ext-link></comment></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="web"><article-title>I presupposti culturali del counselling vaccinale</article-title><source>Istituto Superiore di Sanit&#x00E0;</source><access-date>2024-02-26</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.epicentro.iss.it/vaccini/pdf/Presupposti_culturali_couns.pdf">https://www.epicentro.iss.it/vaccini/pdf/Presupposti_culturali_couns.pdf</ext-link></comment></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ladhani</surname><given-names>SN</given-names> </name><name name-style="western"><surname>Campbell</surname><given-names>H</given-names> </name><name name-style="western"><surname>Amin-Chowdhury</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Lucidarme</surname><given-names>J</given-names> </name><name name-style="western"><surname>Borrow</surname><given-names>R</given-names> </name><name name-style="western"><surname>Ramsay</surname><given-names>ME</given-names> </name></person-group><article-title>Timing of meningococcal vaccination with 4CMenB (Bexsero&#x00AE;) in children with invasive meningococcal group B (MenB) disease in England</article-title><source>Vaccine (Auckl)</source><year>2022</year><month>03</month><day>1</day><volume>40</volume><issue>10</issue><fpage>1493</fpage><lpage>1498</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2021.12.010</pub-id><pub-id pub-id-type="medline">35148913</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azzari</surname><given-names>C</given-names> </name><name name-style="western"><surname>Moriondo</surname><given-names>M</given-names> </name><name name-style="western"><surname>Nieddu</surname><given-names>F</given-names> </name><etal/></person-group><article-title>Effectiveness and impact of the 4CMenB vaccine against Group B meningococcal disease in two Italian regions using different vaccination schedules: a five-year retrospective observational study (2014-2018)</article-title><source>Vaccines (Basel)</source><year>2020</year><month>08</month><day>22</day><volume>8</volume><issue>3</issue><fpage>469</fpage><pub-id pub-id-type="doi">10.3390/vaccines8030469</pub-id><pub-id pub-id-type="medline">32842669</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lodi</surname><given-names>L</given-names> </name><name name-style="western"><surname>Barbati</surname><given-names>F</given-names> </name><name name-style="western"><surname>Amicizia</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Four-component recombinant protein-based vaccine effectiveness against serogroup B meningococcal disease in Italy</article-title><source>JAMA Netw Open</source><year>2023</year><month>08</month><day>1</day><volume>6</volume><issue>8</issue><fpage>e2329678</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.29678</pub-id><pub-id pub-id-type="medline">37594762</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="web"><article-title>Vaccinazioni dell&#x2019;et&#x00E0; pediatrica anno 2022 (coorte 2020)</article-title><source>Ministero della Salute</source><access-date>2025-09-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.salute.gov.it/imgs/C_17_bancheDati_38_0_0_file.pdf">https://www.salute.gov.it/imgs/C_17_bancheDati_38_0_0_file.pdf</ext-link></comment></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biasci</surname><given-names>P</given-names> </name><name name-style="western"><surname>Barretta</surname><given-names>M</given-names> </name><name name-style="western"><surname>Conforti</surname><given-names>G</given-names> </name><name name-style="western"><surname>Doria</surname><given-names>M</given-names> </name><name name-style="western"><surname>Rosati</surname><given-names>GV</given-names> </name></person-group><article-title>Bilanci di salute e vaccinazioni: risultati di una indagine conoscitiva condotta tra i Pediatri di Famiglia associati a FIMP [Article in Italian]</article-title><source>Il Medico Pediatra</source><year>2020</year><volume>29</volume><issue>4</issue><fpage>4</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.36179/2611-5212-2020-33</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Napolitano</surname><given-names>F</given-names> </name><name name-style="western"><surname>D&#x2019;Alessandro</surname><given-names>A</given-names> </name><name name-style="western"><surname>Angelillo</surname><given-names>IF</given-names> </name></person-group><article-title>Investigating Italian parents&#x2019; vaccine hesitancy: a cross-sectional survey</article-title><source>Hum Vaccin Immunother</source><year>2018</year><month>07</month><day>3</day><volume>14</volume><issue>7</issue><fpage>1558</fpage><lpage>1565</lpage><pub-id pub-id-type="doi">10.1080/21645515.2018.1463943</pub-id><pub-id pub-id-type="medline">29641945</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ames</surname><given-names>HM</given-names> </name><name name-style="western"><surname>Glenton</surname><given-names>C</given-names> </name><name name-style="western"><surname>Lewin</surname><given-names>S</given-names> </name></person-group><article-title>Parents&#x2019; and informal caregivers&#x2019; views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence</article-title><source>Cochrane Database Syst Rev</source><year>2017</year><month>02</month><day>7</day><volume>2</volume><issue>2</issue><fpage>CD011787</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD011787.pub2</pub-id><pub-id pub-id-type="medline">28169420</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gentry</surname><given-names>SV</given-names> </name><name name-style="western"><surname>Gauthier</surname><given-names>A</given-names> </name><name name-style="western"><surname>L&#x2019;Estrade Ehrstrom</surname><given-names>B</given-names> </name><etal/></person-group><article-title>Serious gaming and gamification education in health professions: systematic review</article-title><source>J Med Internet Res</source><year>2019</year><volume>21</volume><issue>3</issue><fpage>e12994</fpage><pub-id pub-id-type="doi">10.2196/12994</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montagni</surname><given-names>I</given-names> </name><name name-style="western"><surname>Mabchour</surname><given-names>I</given-names> </name><name name-style="western"><surname>Tzourio</surname><given-names>C</given-names> </name></person-group><article-title>Digital gamification to enhance vaccine knowledge and uptake: scoping review</article-title><source>JMIR Serious Games</source><year>2020</year><month>05</month><day>18</day><volume>8</volume><issue>2</issue><fpage>e16983</fpage><pub-id pub-id-type="doi">10.2196/16983</pub-id><pub-id pub-id-type="medline">32348271</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hakim</surname><given-names>H</given-names> </name><name name-style="western"><surname>Driedger</surname><given-names>SM</given-names> </name><name name-style="western"><surname>Gagnon</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Digital gamification tools to enhance vaccine uptake: scoping review</article-title><source>JMIR Serious Games</source><year>2024</year><month>02</month><day>29</day><volume>12</volume><fpage>e47257</fpage><pub-id pub-id-type="doi">10.2196/47257</pub-id><pub-id pub-id-type="medline">38421688</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="web"><article-title>Design thinking</article-title><source>IDEOU</source><access-date>2025-09-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.ideou.com/pages/design-thinking">https://www.ideou.com/pages/design-thinking</ext-link></comment></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="web"><article-title>Storyline 360</article-title><source>Articulate</source><year>2025</year><access-date>2025-09-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.articulate.com/lp/storyline-version-articulate-360/">https://www.articulate.com/lp/storyline-version-articulate-360/</ext-link></comment></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="web"><article-title>SCORM 12 overview for developers</article-title><source>SCORM.com</source><year>2025</year><access-date>2025-09-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://scorm.com/scorm-explained/technical-scorm/scorm-12-overview-for-developers/">https://scorm.com/scorm-explained/technical-scorm/scorm-12-overview-for-developers/</ext-link></comment></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="web"><source>TalentLMS</source><year>2025</year><access-date>2025-09-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.talentlms.com/">https://www.talentlms.com/</ext-link></comment></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="web"><article-title>Agenzia italiana del farmaco: linee guida per la classificazione e conduzione degli studi osservazionali sui farmaci (GU serie generale n76 del 31-03-2008)</article-title><source>Gazzetta Ufficiale</source><year>2008</year><comment><ext-link ext-link-type="uri" xlink:href="https://www.gazzettaufficiale.it/eli/id/2008/03/31/08A02109/sg">https://www.gazzettaufficiale.it/eli/id/2008/03/31/08A02109/sg</ext-link></comment></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tozzi</surname><given-names>AE</given-names> </name><name name-style="western"><surname>Gesualdo</surname><given-names>F</given-names> </name><name name-style="western"><surname>D&#x2019;Ambrosio</surname><given-names>A</given-names> </name><name name-style="western"><surname>Pandolfi</surname><given-names>E</given-names> </name><name name-style="western"><surname>Agricola</surname><given-names>E</given-names> </name><name name-style="western"><surname>Lopalco</surname><given-names>P</given-names> </name></person-group><article-title>Can digital tools be used for improving immunization programs?</article-title><source>Front Public Health</source><year>2016</year><volume>4</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2016.00036</pub-id><pub-id pub-id-type="medline">27014673</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eley</surname><given-names>CV</given-names> </name><name name-style="western"><surname>Young</surname><given-names>VL</given-names> </name><name name-style="western"><surname>Hayes</surname><given-names>CV</given-names> </name><name name-style="western"><surname>Verlander</surname><given-names>NQ</given-names> </name><name name-style="western"><surname>McNulty</surname><given-names>CAM</given-names> </name></person-group><article-title>Young people&#x2019;s knowledge of antibiotics and vaccinations and increasing this knowledge through gaming: mixed-methods study using e-bug</article-title><source>JMIR Serious Games</source><year>2019</year><month>02</month><day>1</day><volume>7</volume><issue>1</issue><fpage>e10915</fpage><pub-id pub-id-type="doi">10.2196/10915</pub-id><pub-id pub-id-type="medline">30707096</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Healy</surname><given-names>P</given-names> </name><name name-style="western"><surname>Lu</surname><given-names>C</given-names> </name><name name-style="western"><surname>Silk</surname><given-names>JS</given-names> </name><etal/></person-group><article-title>An exposure-based video game (dr. zoo) to reduce needle phobia in children aged 3 to 6 years: development and mixed methods pilot study</article-title><source>JMIR Serious Games</source><year>2023</year><month>10</month><day>16</day><volume>11</volume><fpage>e42025</fpage><pub-id pub-id-type="doi">10.2196/42025</pub-id><pub-id pub-id-type="medline">37843885</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Hernik</surname><given-names>J</given-names> </name><name name-style="western"><surname>Jaworska</surname><given-names>E</given-names> </name></person-group><article-title>The effect of enjoyment on learning</article-title><conf-name>12th International Technology, Education and Development Conference</conf-name><conf-date>Mar 5-7, 2018</conf-date><conf-loc>Valencia, Spain</conf-loc><pub-id pub-id-type="doi">10.21125/inted.2018.1087</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="web"><article-title>Good publication practice (GPP 2022) guidelines</article-title><source>International Society for Medical Publication Professionals</source><access-date>2025-09-29</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.ismpp.org/gpp-2022">https://www.ismpp.org/gpp-2022</ext-link></comment></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>Questions that Meningioca users were asked following each module.</p><media xlink:href="pediatrics_v8i1e70049_app1.docx" xlink:title="DOCX File, 28 KB"/></supplementary-material></app-group></back></article>